Outcome of Longterm Antithrombotic Therapy in Acute Coronary Syndrome Patients
This trial is active, not recruiting.
|Conditions||acute coronary syndrome, myocardial infarction|
|Start date||January 2006|
|Trial size||78000 participants|
|Trial identifier||NCT01623700, U-11-001|
This observational study will based on the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA) and the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) which since 2009 are merged into The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART).
The aim of this study is to investigate the impact of different antithrombotic treatment options (treatment duration, type of treatment and combination of treatments) in Acute Coronary Syndrome (ACS) patients on outcomes such as recurrent ischemic events and mortality.
number of patients with adverse events in patient groups with different antithrombotic treatment strategies
time frame: up to 5 years and 6 months
Male or female participants of any age.
- Patient with an event of ACS under the study period
- Patient found in the National Registry of Drug Prescriptions and treated or not treated with antithrombotic drug/s (acetylsalicylic acid and/or either clopidogrel/ticlopidine/prasugrel and/or warfarin)
- Patients will not be excluded from the database if they fulfill inclusion criteria.
|Official title||A Retrospective Epidemiological Study to Investigate Outcome and Mortality With Longterm Antithrombotic Therapy in Acute Coronary Syndrome Patients|
|Principal investigator||Stefan James, MD, PhD|
Call for more information